(Reuters) – A panel of the European drug regulator on Monday approved scaling up manufacturing of AstraZeneca’s COVID-19 vaccine.
An existing manufacturing site operated by Universal Farma in Guadalajara, Spain, will add a second filling line for the vaccine, the European Medicines Agency’s human medicines committee said in a statement.
The scaling up is expected to support the continued supply of the vaccine, including for donations to third countries through COVAX.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Susan Fenton)
